Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-05

FDA Approved: POTASSIUM CHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' supplemental application for Potassium Chloride, approving changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium chloride (Potassium chloride)

Snippet

SUPPL AP for POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)